Market Currents
NuVasive (NUVA -13.8%) sells off after reporting Q3 revenue of $132.9M (+10.5% Y/Y) and EPS of...
-
Friday, October 28, 2011, 10:39 AM ETNuVasive (NUVA -13.8%) sells off after reporting Q3 revenue of $132.9M (+10.5% Y/Y) and EPS of $0.26; the latter beat by $0.03, but the former missed by $1.3M. In addition, NuVasive, which is mired in a costly legal battle with MDT, is guiding for 2011 revenue of $538M-$540M and EPS of $1.01-$1.02, below a consensus of $542M and $1.05.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
